Maxis AI launches MaxisAI Holarchy, the first Verticalized Context Layer for life sciences.Learn More

    White Papers Gated White Paper

    White Paper

    AI and Human Oversight: A Risk-Based Framework for Alignment

    A practical risk-based framework for preserving human judgment, ethics, accountability, patient safety, and regulatory confidence as AI transforms clinical research and life sciences.

    White PaperNovember 15, 2025White Paper
    AI and Human Oversight whitepaper artwork featuring co-author Laxmiraju Kandikatla and a risk-based framework for alignment

    About this white paper

    What's inside

    As AI transforms clinical development, data management, and decision-making, preserving human judgment, ethics, and accountability is essential. This whitepaper presents a structured, scalable framework that links AI model risk with the right level of human oversight. Drawing on examples from clinical operations, pharmacovigilance, and patient data management, it explains how Human-in-Command, Human-in-the-Loop, and Human-on-the-Loop models can balance automation with patient safety, data integrity, compliance, and regulatory confidence.

    Key takeaways

    What you'll learn

    • How to identify where human involvement matters most, from AI-enabled patient recruitment to risk-based monitoring and adverse event reporting.
    • How structured oversight preserves investigator judgment, patient safety, human agency, and transparent clinical decisions.
    • How to apply ISO 31000 and EU AI Act principles to align model risk with oversight intensity in GxP-regulated environments.
    • How Human-in-Command, Human-in-the-Loop, and Human-on-the-Loop models can support accountable clinical operations.
    • How risk-based human oversight strengthens trust, auditability, and regulatory confidence without slowing responsible innovation.
    Laxmiraju Kandikatla

    About the author

    Laxmiraju Kandikatla

    CSV Lead, Maxis AI

    Laxmiraju Kandikatla brings 13+ years of experience across life sciences, pharmaceutical, and clinical research sectors. As CSV Lead at Maxis AI, he leads validation and compliance frameworks for clinical research systems, with hands-on experience across GAMP 5 Categories 3, 4, and 5. He holds an M.Pharm from NIPER and is an ASQ-Certified Quality Auditor, with expertise in GxP, 21 CFR Part 11, EU Annex 11, and FDA guidance.